1Ashwell M (2005) A review of the food standards agency's optimal nutrition research programme. Nutr Bull 30, 76–84.
2Calder PC (2007) Immunological parameters: what do they mean? J Nutr 137, 773S–780S.
3Albers R, Antoine J-M, Bourdet-Sicard R, et al. (2007) Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 94, 452–481.
4Cummings JH, Antoine JM, Azpiroz F, et al. (2004) PASSCLAIM–gut health and immunity. Eur J Nutr 43, Suppl. 2, II118–II173.
5Sijben JWC & Calder PC (2007) Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Proc Nutr Soc 66, 237–259.
6Lesourd B (2007) Nutritional factors and immunological ageing. Proc Nutr Soc 65, 319–325.
7Broome CS, McArdle F, Kyle JAM, et al. (2004) An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am J Clin Nutr 80, 154–162.
8Hawkes WC, Kelley DS & Taylor PC (2001) The effects of dietary selenium on the immune system in healthy men. Biol Trace Elem Res 81, 189–213.
9Haase H, Overbeck S & Rink L (2008) Zinc supplementation for the treatment or prevention of disease: current status and future perspectives. Exp Gerontol 43, 394–408.
10Kahmann L, Uciechowski P, Warmuth S, et al. (2008) Zinc supplementation in the elderly reduces spontaneous inflammatory cytokine release and restores T cell functions. Rejuvenation Res 11, 227–237.
11Mariani E, Neri S, Cattini L, et al. (2008) Effect of zinc supplementation on plasma IL-6 and MCP-1 production and NK cell function in healthy elderly: interactive influence of +647 MT1a and − 174 IL-6 polymorphic alleles. Exp Gerontol 43, 462–471.
12Hodkinson CF, Kelly M, Alexander HD, et al. (2007) Effect of zinc supplementation on the immune status of healthy older individuals aged 55–70 years: the ZENITH Study. J Gerontol A Biol Sci Med Sci 62, 598–608.
13Cantorna MT (2008) Vitamin D and multiple sclerosis: an update. Nutr Rev 66, S135–S138.
14Cantorna MT, Yu S & Bruce D (2008) The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med 29, 369–375.
15Yu S & Cantorna MT (2008) The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci U S A 105, 5207–5212.
16Cantorna MT, Zhu Y, Froicu M, et al. (2004) Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80, 1717S–1720S.